Checkpoint Surgical

Checkpoint Surgical is a leader in the peripheral nerve care market, empowering surgeons with innovative tools for nerve protection, identification, and repair. The company's mission is to improve patient and physician quality of life through advancements in nerve surgery, supported by a comprehensive portfolio of stimulators, biomaterials, and instruments. It actively engages in surgeon education and clinical research, including a pivotal trial for its investigational nerve regeneration system, Regen10®. Strategically, Checkpoint is expanding its product offerings across the continuum of intraoperative nerve care.

Integrated platform for intraoperative nerve care featuring proprietary biphasic waveform nerve stimulators, dehydrated placental membrane allograft biomaterials, and specialized nerve-specific surgical instruments.

Total raised: $26M

Checkpoint competes with companies like AxoGen and Integra LifeSciences in nerve repair, and various providers of intraoperative nerve stimulators. Its differentiation lies in its focused, integrated portfolio for nerve surgery, proprietary stimulation technology, and a strong commitment to surgeon education and community building, which fosters brand loyalty.